PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
IEX Last Trade
1.85
0.010 0.541%
Share volume: 37,622
Last Updated: Fri 27 Dec 2024 04:30:09 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.05%
PREVIOUS CLOSE
CHG
CHG%
$1.84
0.01
0.54%
Fundamental analysis
21%
Profitability
0%
Dept financing
19%
Liquidity
75%
Performance
30%
Performance
5 Days
1.04%
1 Month
10.17%
3 Months
12.07%
6 Months
44.44%
1 Year
-81.03%
2 Year
-75.69%
Key data
Stock price
$1.85
DAY RANGE
$1.82 - $1.92
52 WEEK RANGE
$1.28 - $10.34
52 WEEK CHANGE
-$81.18
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Christian O. Henry
Region: US
Website: pacb.com
Employees: 730
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: pacb.com
Employees: 730
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.
Recent news